Viruses (Mar 2023)

Impact Assessment of vB_KpnP_K1-ULIP33 Bacteriophage on the Human Gut Microbiota Using a Dynamic In Vitro Model

  • Fanny Laforêt,
  • Céline Antoine,
  • Sarah Lebrun,
  • Irma Gonza,
  • Elizabeth Goya-Jorge,
  • Caroline Douny,
  • Jean-Noël Duprez,
  • Marie-Louise Scippo,
  • Bernard Taminiau,
  • Georges Daube,
  • Abdoulaye Fall,
  • Damien Thiry,
  • Véronique Delcenserie

DOI
https://doi.org/10.3390/v15030719
Journal volume & issue
Vol. 15, no. 3
p. 719

Abstract

Read online

New control methods are needed to counter antimicrobial resistances and the use of bacteriophages as an alternative treatment seems promising. To that end, the effect of the phage vB_KpnP_K1-ULIP33, whose host is the hypervirulent Klebsiella pneumoniae SA12 (ST23 and capsular type K1), was assessed on intestinal microbiota, using an in vitro model: the SHIME® system (Simulator of the Human Intestinal Microbial Ecosystem). After stabilization of the system, the phage was inoculated for 7 days and its persistence in the different colons was studied until its disappearance from the system. The concentration of short chain fatty acids in the colons showed good colonization of the bioreactors by the microbiota and no significant effect related to the phage treatment. Diversity (α and β), the relative abundance of bacteria, and qPCR analysis targeting different genera of interest showed no significant variation following phage administration. Even if further in vitro studies are needed to assess the efficacy of this phage against its bacterial host within the human intestinal ecosystem, the phage ULIP33 exerted no significant change on the global colonic microbiota.

Keywords